Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

medRxiv logoLink to medRxiv
[Preprint]. 2026 Feb 27:2026.02.26.26346165. [Version 1] doi: 10.64898/2026.02.26.26346165

Familial medullary thyroid carcinoma secondary to an SLC30A9 intragenic deletion and translation reinitiation

Donato Iacovazzo, Federica Begalli, Oniz Suleyman, Márton Doleschall, Maria Alevizaki, Kevin E Ashelford, Sherine Awad Mahmoud, Anne Barlier, Sayka Barry, Caroline Brain, Claudia P Cabrera, Frédéric Castinetti, Sabrina Chiloiro, Kevin Colclough, Alexandra Csábi, Maralyn R Druce, Pinaki Dutta, Jawid M Fatih, William D Foulkes, Mira Gandhi, Christopher M Grochowski, Charlotte L Hall, Barbara Jarząb, Kathleen O Klein, Jolanta Krajewska, Tom R Kurzawinski, Sebastiaan Lamers, Francesca Lugli, Kesson Magid, Rebecca Margraf, Carmen S Martin, Jes S Mathiesen, Radu Mihai, Patrick J Morrison, Monika Mozere, Małgorzata Oczko-Wojciechowska, Martina Owens, Luka Ozretić, Attila Patócs, Serena Piacentini, Jaya Punetha, Pauline Romanet, Suvi Savola, Stefan Schoenfelder, David M Scott-Coombes, Horia Stanescu, Mehmet Tekman, Laura E Thomas, Miklós Tóth, Steven W Wingett, Michael Witcher, Claudia MB Carvalho, Martin Franke, Robert Kleta, James R Lupski, Julian R Sampson, Laura De Marinis, Márta Korbonits
PMCID: PMC12990992  PMID: 41847600

Abstract

While most individuals with familial medullary thyroid carcinoma (fMTC) carry RET mutations, in some instances the causative mutations remain unknown. We studied two related families with RET -negative fMTC in 21 affected individuals through linkage analysis, exome/genome sequencing, and high-density array comparative genomic hybridization. We identified a novel heterozygous 40kb intragenic SLC30A9 deletion which segregated with the disease in all affected individuals. The mutant transcript escaped nonsense-mediated decay and resulted in the production of N-terminally truncated proteins via translation reinitiation from in-frame AUG codons located downstream of the deletion. These proteins showed increased stability and their expression in an MTC cell line increased cell proliferation and clonogenic capacity, supporting an oncogenic role. These findings expand the genetic background of fMTC beyond RET mutations and implicate translation reinitiation in the etiology of cancer susceptibility syndromes secondary to structural genomic variants.

Full Text Availability

The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.


Articles from medRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES